Received dividend from consolidated subsidiary LINICAL KOREA CO., LTD. Amount is 1,000 million Korean won (110 million yen), receipt date on August 5, 2026. It will be recorded as ordinary income in the individual financial statements for the fiscal year ending March 2027 and has no impact on consolidated results.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2183","jir_company_name":"Lynical, Inc.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-08-05","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/2183-20260805-01.pdf","jir_short_summary":"Received dividend from consolidated subsidiary LINICAL KOREA CO., LTD. Amount is 1,000 million Korean won (110 million yen), receipt date on August 5, 2026. It will be recorded as ordinary income in the individual financial statements for the fiscal year ending March 2027 and has no impact on consolidated results.","jir_summary":"### Key points of the news\nWe received a dividend from the consolidated subsidiary LINICAL KOREA CO., LTD., amounting to 1,000 million Korean won (110 million yen). Receipt date is August 5, 2026. In the fiscal year ending March 2027, it will be recorded as ordinary income in the separate financial statements, with no impact on the consolidated results.\n\n### Impact and considerations going forward\nSince the dividend is from a consolidated subsidiary, it does not affect the group's consolidated results. However, it may affect the individual financial statements. Although exchange rate information is provided, since the dividend is in Korean won, exchange effects should be considered separately.","jir_financial_highlights":"Dividend amount: 1,000 million Korean won (110 million yen) (Unknown)\nDividend receipt date: August 5, 2026 (Unknown)","jir_category":"","jir_hashtags":"#Reclinical, #dividend, #IR","jir_key_figures":"Dividend amount: 1,000 million Korean won (110 million yen)\nDividend receipt date: August 5, 2026\nTarget consolidated subsidiary: LINICAL KOREA CO., LTD.","jir_meta_title":"\u3010Lynical\u3011 Announcement of Dividend Receipt from Consolidated Subsidiary | August 2026","jir_meta_description":"Announcement of dividend receipt from Lynical's consolidated subsidiary LINICAL KOREA CO., LTD. Amount is 1,000 million Korean won (110 million yen); recorded in the fiscal year ending March 2027 as ordinary income, with no impact on consolidated results.","jir_og_title":"\u3010Lynical\u3011 Dividend Receipt from Consolidated Subsidiary | August 2026","jir_og_description":"Announcement of dividend receipt from the consolidated subsidiary LINICAL KOREA CO., LTD. Amount is 1,000 million Korean won; recorded as ordinary income in the individual financial statements, no impact on consolidated results.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59407,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"dividend","footnotes":""},"sector":[],"importance":[],"class_list":["post-95867","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n